JESSICA YOUNG: Open Payments
NPI 1952787806 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 43 payments from 14 companies in 2025. Trend: 2023 $130 · 2024 $780 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $295 |
| Lilly USA, LLC | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $142 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 5 | $83 |
| ABBVIE INC. | 3 | $76 |
| PFIZER INC. | 3 | $60 |
| Astellas Pharma US Inc | 1 | $25 |
| Amgen Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
Products named: AIRSUPRA, REXULTI, MOUNJARO, NUZYRA, Wegovy, PREVNAR 20, UBRELVY, Veozah.
Industry payments across CO — which companies pay providers there.
